CBT R&D Expense Growth
-6.35%Fiscal year
Period ending:
CBT FY R&D Growth (YoY)%
42.26%-50.03%
1985-09-302025-09-30
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.
CBT r&d expense growth history
Year-over-year research & development expense growth. The available annual fiscal periods series contains 41 observations from Sep 30, 1985 to Sep 30, 2025.
| Period ending | R&D Expense Growth |
|---|---|
| -6.3492% | |
| 10.5263% | |
| 3.6364% | |
| -1.7857% | |
| -1.7544% | |
| -5% | |
| -9.0909% | |
| 17.8571% | |
| 5.6604% | |
| -8.6207% | |
| -3.3333% | |
| -18.9189% | |
| 1.3699% | |
| 10.6061% | |
| -5.7143% | |
| -1.4085% | |
| -4.0541% | |
| 7.2464% | |
| 18.9655% | |
| -1.6949% | |
| 11.3208% | |
| -17.1875% | |
| 33.3333% | |
| 0% | |
| 11.6279% | |
| -41.0959% | |
| -11.7291% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |
Compare r&d expense growth
All CBT financial metrics · CBT stock overview · How to interpret financial metrics
